Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Livija Deban"'
Publikováno v:
Engineering Biology, Vol 8, Iss 2-3, Pp 31-40 (2024)
Abstract Living cures are cell‐based, programmable therapies that integrate the latest learnings in immunology and synthetic biology. Although Adoptive Cell Therapies (ACTs) have transformed the treatment landscape of haematological malignancies by
Externí odkaz:
https://doaj.org/article/95517735e34a4048a8450c3b73c78a70
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/6a52d98222084036ac95270d05900adf
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/0689003904cd4129bf16310410f14c27
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/ef307de4fd5a4b76bc170be6c98a97e6
Autor:
Danka Grčević, Marina Sironi, Sonia Valentino, Livija Deban, Hrvoje Cvija, Antonio Inforzato, Nataša Kovačić, Vedran Katavić, Tomislav Kelava, Ivo Kalajzić, Alberto Mantovani, Barbara Bottazzi
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Pentraxin 3 (PTX3) is an inflammatory mediator acting as a fluid-phase pattern recognition molecule and playing an essential role in innate immunity and matrix remodeling. Inflammatory mediators also contribute to skeletal homeostasis, operating at m
Externí odkaz:
https://doaj.org/article/f48ea8027f78452d9923f6f0c2efd391
Autor:
Barbara Bottazzi, Laura Santini, Silvana Savino, Marzia M Giuliani, Ana I Dueñas Díez, Giuseppe Mancuso, Concetta Beninati, Marina Sironi, Sonia Valentino, Livija Deban, Cecilia Garlanda, Giuseppe Teti, Mariagrazia Pizza, Rino Rappuoli, Alberto Mantovani
Publikováno v:
PLoS ONE, Vol 10, Iss 3, p e0120807 (2015)
Long pentraxin 3 (PTX3) is a non-redundant component of the humoral arm of innate immunity. The present study was designed to investigate the interaction of PTX3 with Neisseria meningitidis. PTX3 bound acapsular meningococcus, Neisseria-derived outer
Externí odkaz:
https://doaj.org/article/a76ebd7f3d084e0994ac22268b260ade
Autor:
Andrew Scott, Matthieu Besneux, Oluwatobiloba Oke, Mary Chol, Claudia Prevosto, Nicholas Glanville, Livija Deban
Publikováno v:
Regular and Young Investigator Award Abstracts.
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 3287, p 3287 (2021)
International Journal of Molecular Sciences
Volume 22
Issue 6
International Journal of Molecular Sciences
Volume 22
Issue 6
Enteric fever is a major global healthcare issue caused largely by Salmonella enterica serovars Typhi and Paratyphi A. The objective of this study was to develop a novel, bivalent oral vaccine capable of protecting against both serovars. Our approach
Autor:
Lenka Polak, Tobi Oke, Livija Deban, Denise Nardelli-Haefliger, Nicholas Glanville, Sonia Domingos-Pereira
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundMicrobial immunotherapy, in the form of intravesical Bacillus Calmette-Guérin (BCG), is the standard-of-care for non-muscle invasive bladder cancer (NMIBC). BCG therapy is associated with significant side-effects, high disease recurrence a
Autor:
James Edward Ackroyd, Chander Peddaboina, Eugene Zhukovsky, Arnima Bisht, Lindsey Hudson, San Lin Lou, Robert Boyd, Abderrahim Fandi, Livija Deban, Martin Barnes, Angelo Kaplan, Christian Rohlff, Murray Cox, Jason D. Allen, Nickolas Attanasio
Publikováno v:
Cancer Research. 80:5167-5167
Identification of novel targets in cancer immunotherapy is needed to address the significant number of patients that either do not respond to current therapies or encounter unacceptable toxicities. The first two generations of immuno-oncology drugs h